These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
570 related articles for article (PubMed ID: 26844759)
1. The therapeutic potential of cell identity reprogramming for the treatment of aging-related neurodegenerative disorders. Smith DK; He M; Zhang CL; Zheng JC Prog Neurobiol; 2017 Oct; 157():212-229. PubMed ID: 26844759 [TBL] [Abstract][Full Text] [Related]
2. Induced pluripotency and direct reprogramming: a new window for treatment of neurodegenerative diseases. Li R; Bai Y; Liu T; Wang X; Wu Q Protein Cell; 2013 Jun; 4(6):415-24. PubMed ID: 23686735 [TBL] [Abstract][Full Text] [Related]
3. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology. Liu Y; Deng W Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934 [TBL] [Abstract][Full Text] [Related]
4. Somatic cell reprogramming as a tool for neurodegenerative diseases. Ebrahimi A; Keske E; Mehdipour A; Ebrahimi-Kalan A; Ghorbani M Biomed Pharmacother; 2019 Apr; 112():108663. PubMed ID: 30970509 [TBL] [Abstract][Full Text] [Related]
5. Reprogramming of somatic cells to induced neural stem cells. Shahbazi E; Mirakhori F; Ezzatizadeh V; Baharvand H Methods; 2018 Jan; 133():21-28. PubMed ID: 28939501 [TBL] [Abstract][Full Text] [Related]
7. Induced pluripotent stem cells and their use in cardiac and neural regenerative medicine. Skalova S; Svadlakova T; Shaikh Qureshi WM; Dev K; Mokry J Int J Mol Sci; 2015 Feb; 16(2):4043-67. PubMed ID: 25689424 [TBL] [Abstract][Full Text] [Related]
8. Disease Modeling of Neurodegenerative Disorders Using Direct Neural Reprogramming. Legault EM; Bouquety J; Drouin-Ouellet J Cell Reprogram; 2022 Oct; 24(5):228-251. PubMed ID: 35749150 [TBL] [Abstract][Full Text] [Related]
9. [Progress in induced pluripotent stem cell research for age-related neurodegenerative diseases]. Ito D; Yagi T; Suzuki N Brain Nerve; 2013 Mar; 65(3):283-8. PubMed ID: 23475520 [TBL] [Abstract][Full Text] [Related]
10. Cell reprogramming: Therapeutic potential and the promise of rejuvenation for the aging brain. López-León M; Outeiro TF; Goya RG Ageing Res Rev; 2017 Nov; 40():168-181. PubMed ID: 28903069 [TBL] [Abstract][Full Text] [Related]
11. Progress and Challenges of Cell Replacement Therapy for Neurodegenerative Diseases Based on Direct Neural Reprogramming. Chen Y; Pu J; Zhang B Hum Gene Ther; 2016 Dec; 27(12):962-970. PubMed ID: 27589383 [TBL] [Abstract][Full Text] [Related]
12. Introduction for Stem Cell-Based Therapy for Neurodegenerative Diseases. Han F; Lu P Adv Exp Med Biol; 2020; 1266():1-8. PubMed ID: 33105491 [TBL] [Abstract][Full Text] [Related]
13. Advances in reprogramming-based study of neurologic disorders. Nityanandam A; Baldwin KK Stem Cells Dev; 2015 Jun; 24(11):1265-83. PubMed ID: 25749371 [TBL] [Abstract][Full Text] [Related]
14. Preparation of Neural Stem Cells and Progenitors: Neuronal Production and Grafting Applications. Zholudeva LV; Jin Y; Qiang L; Lane MA; Fischer I Methods Mol Biol; 2021; 2311():73-108. PubMed ID: 34033079 [TBL] [Abstract][Full Text] [Related]